2 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Pediatric Osteosarcoma: new trials by email Literature Review of Pediatric Osteosarcoma trials Research Report on Pediatric Osteosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse Experimental group : Cabometyx ® 40mg/m2/day (Max: 60mg/day) , Treatment schedule : Daily**, day 1-28 during 4 weeks (ie. 1 cycle) during 12 cycles - Osteosarcoma, Pediatric Osteosarcoma | Phase 3 | Recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 530 | 2026-10-07 | 2026-10-26 |
| Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma Cyclophosphamide, Fludarabine, Mesna - Pediatric Osteosarcoma | Phase 2 | Recruiting | St. Jude Children's Research Hospital | 41 | 2026-09-01 | 2026-09-01 |
Osteosarcoma (2)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Bone Tissue (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Sarcoma (2)
Blood Component Removal (1) · Cyclophosphamide (1) · MAX protein, human (1) · Mesna (1) · fludarabine (1)
Gustave Roussy, Cancer Campus, Grand Paris (1) · St. Jude Children's Research Hospital (1)
Denmark (1) · Finland (1) · France (1) · Italy (1) · Netherlands (1) · Poland (1) · Spain (1) · Sweden (1) · United States (1)
Julie Park, MD (1)
2023 (1)